Rock Springs Capital Management LP Q1 2019 Filing
Filed May 15, 2019
Portfolio Value
$2.6T
Holdings
131
Report Date
Q1 2019
Filing Type
13F-HR
All Holdings (131 positions)
| Stock | Value |
|---|---|
UNHUNITEDHEALTH GROUP INC | $146.1B |
—GW PHARMACEUTICALS PLC | $118.0B |
AMRNAMARIN CORP PLC | $93.9B |
ISRGINTUITIVE SURGICAL INC | $87.0B |
WCGEURWELLCARE HEALTH PLANS INC | $86.3B |
NBIXNEUROCRINE BIOSCIENCES INC | $74.4B |
—SPARK THERAPEUTICS INC | $61.2B |
HCAHCA HEALTHCARE INC | $59.3B |
PCRXPACIRA PHARMACEUTICALS INC | $47.6B |
EHCENCOMPASS HEALTH CORP | $46.7B |
RAREULTRAGENYX PHARMACEUTICAL IN | $40.2B |
SRPTSAREPTA THERAPEUTICS INC | $39.9B |
TFXTELEFLEX INC | $39.3B |
IRTCIRHYTHM TECHNOLOGIES INC | $37.5B |
VRTXVERTEX PHARMACEUTICALS INC | $37.3B |
BSXBOSTON SCIENTIFIC CORP | $37.2B |
SYKSTRYKER CORP | $35.4B |
EWEDWARDS LIFESCIENCES CORP | $35.1B |
EXASEXACT SCIENCES CORP | $34.4B |
PENPENUMBRA INC | $33.1B |
ALXNALEXION PHARMACEUTICALS INC | $32.8B |
MDGLMADRIGAL PHARMACEUTICALS INC | $32.0B |
—PORTOLA PHARMACEUTICALS INC | $30.4B |
AFWALIGN TECHNOLOGY INC | $29.9B |
MOHMOLINA HEALTHCARE INC | $29.5B |
—WRIGHT MED GROUP N V | $29.0B |
ONCBEIGENE LTD | $28.4B |
ACHCACADIA HEALTHCARE COMPANY IN | $27.1B |
NVTA1EURINVITAE CORP | $26.9B |
IDXXIDEXX LABS INC | $26.9B |
INCYINCYTE CORP | $26.9B |
PRAHPRA HEALTH SCIENCES INC | $26.5B |
ASNDASCENDIS PHARMA A S | $25.1B |
IM8NINSMED INC | $24.7B |
BAXBAXTER INTL INC | $24.4B |
COLLCOLLEGIUM PHARMACEUTICAL INC | $23.9B |
—RADIUS HEALTH INC | $23.4B |
BIIBBIOGEN INC | $23.0B |
ARGXARGENX SE | $22.7B |
TMOTHERMO FISHER SCIENTIFIC INC | $22.2B |
2L9BLUEPRINT MEDICINES CORP | $22.0B |
ALNYALNYLAM PHARMACEUTICALS INC | $21.8B |
—EPIZYME INC | $21.7B |
—ALDER BIOPHARMACEUTICALS INC | $21.3B |
CVETUSDCOVETRUS INC | $20.7B |
—AUDENTES THERAPEUTICS INC | $20.4B |
—MEDICINES CO | $20.4B |
GLPGGALAPAGOS NV | $19.4B |
—RETROPHIN INC | $18.8B |
—RA PHARMACEUTICALS INC | $18.0B |
PBYIPUMA BIOTECHNOLOGY INC | $17.8B |
SGENEURSEATTLE GENETICS INC | $17.7B |
CELGCELGENE CORP | $17.5B |
FGENEURFIBROGEN INC | $16.6B |
ALLKGUSDALLAKOS INC | $16.4B |
—IMMUNOMEDICS INC | $15.4B |
—INTERSECT ENT INC | $14.9B |
SG7SAGE THERAPEUTICS INC | $14.7B |
AG8AGILENT TECHNOLOGIES INC | $14.7B |
CICIGNA CORP NEW | $14.5B |
—OBSEVA SA | $14.3B |
GHGUARDANT HEALTH INC | $13.8B |
WSTWEST PHARMACEUTICAL SVSC INC | $13.8B |
AM6AMICUS THERAPEUTICS INC | $13.6B |
—BIOHAVEN PHARMACTL HLDG CO L | $13.4B |
MRTXEURMIRATI THERAPEUTICS INC | $13.2B |
GBTUSDGLOBAL BLOOD THERAPEUTICS IN | $13.0B |
—ZOGENIX INC | $12.9B |
AXGNAXOGEN INC | $12.7B |
TBPHTHERAVANCE BIOPHARMA INC | $12.5B |
ANABANAPTYSBIO INC | $12.4B |
ZLABZAI LAB LTD | $12.2B |
BMRNBIOMARIN PHARMACEUTICAL INC | $12.0B |
—RTI SURGICAL HOLDINGS INC | $11.7B |
—PHASEBIO PHARMACEUTICALS INC | $10.8B |
RIGLUSDRIGEL PHARMACEUTICALS INC | $10.8B |
—DERMIRA INC | $10.5B |
—TRANSLATE BIO INC | $10.3B |
FIXXEURHOMOLOGY MEDICINES INC | $10.3B |
ACRSACLARIS THERAPEUTICS INC | $10.2B |
FRPTFRESHPET INC | $9.9B |
—ODONATE THERAPEUTICS INC | $9.8B |
AXNX*AXONICS MODULATION TECH INC | $9.6B |
CBAYUSDCYMABAY THERAPEUTICS INC | $9.5B |
NVCRNOVOCURE LTD | $9.4B |
CHRSCOHERUS BIOSCIENCES INC | $9.1B |
ASMBASSEMBLY BIOSCIENCES INC | $8.9B |
HRTXHERON THERAPEUTICS INC | $8.6B |
IFRXINFLARX NV | $8.5B |
—MYOVANT SCIENCES LTD | $8.3B |
—ACHILLION PHARMACEUTICALS IN | $8.0B |
AGIOAGIOS PHARMACEUTICALS INC | $7.9B |
—MERSANA THERAPEUTICS INC | $7.4B |
—CLEMENTIA PHARMACEUTICALS IN | $7.2B |
—BLUEBIRD BIO INC | $7.1B |
—FIVE PRIME THERAPEUTICS INC | $6.8B |
SPROSPERO THERAPEUTICS INC | $6.7B |
—GLOBAL CORD BLOOD CORPORATIO | $6.5B |
AGLEUSDAEGLEA BIOTHERAPEUTICS INC | $6.4B |
CLVSEURCLOVIS ONCOLOGY INC | $6.4B |
Page 1 of 2Next